About | Free Trial

Last Update

2015-07-25T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Charles Saldarini?

Mr. Charles Saldarini T.

Founder and Chief Executive Officer

The Charles T. Saldarini Group

The Charles T. Saldarini Group

Background Information

Employment History

Chief Executive Officer
The Charles T. Saldarini Group

Recognized Expert In Bio-Pharmaceutical Services
Mid Atlantic Fund

President
PDI , Inc.

Vice Chairman and Chief Executive Officer
PDI , Inc.

Chief Executive Officer
PDI , Inc.

Head of Global Business Development
Octagon Clinical Research Solutions

Managing Partner
Votetocracy

Chief Executive Officer
Sentrx

Chief Executive Officer and Vice Chairman
Sentrx

Affiliations

Board Member
Rapid Pathogen Screening Inc

Member Board of Directors
Rapid Pathogen Screening Inc

Venture Advisor
Mid Atlantic Fund

Board Member
Octagon Clinical Research Solutions

Board Member
Cadient Group

Board Member
Informed Medical Communications Inc

Education

BA
Political Science and Communications Management
Syracuse University

Web References (151 Total References)


Structured Elements - Leadership

www.i-blink.com, 25 July 2015 [cached]

Charles T. Saldarini

Charles T. Saldarini is the Founder/CEO of The Charles T. Saldarini Group, which evaluates both emerging and commercial stage companies in life sciences. ince 2006, he has been frequently engaged to provide strategic assessments for private equity investment, commercial product development and service company growth opportunities. e is an expert in biopharmaceutical services with substantial experience in product sales and marketing.
Prior to 2006, Saldarini spent 18 years with PDI (NASDAQ:PDII), where he was a major force in driving development of the contract sales industry.Saldarini led PDI from its earliest stage, built its reputation as a premier provider and drove its service revenue growth from ~$1M to $365M. hroughout his tenure, he oversaw creation of all infrastructure, systems and talent growth supporting an employee population of 3,000 and a world class client base.Saldarini's leadership enabled a successful public capitalization, as well as multiple acquisitions and strategic partnerships. t his departure as Vice Chairman and CEO in 2005, PDI was debt free, held over $100M in cash and was well positioned as a complete commercial services provider.


Board of Directors

www.rpsdetectors.com, 16 July 2015 [cached]

Back row (standing - left to right): Charles Saldarini, Stephen La Neve, Caroline Popper

...
Charles T. Saldarini Director
Charles Saldarini is an expert in biopharmaceutical services and a proven leader across all phases of growth and turnaround. He is currently the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Saldarini served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture. Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Saldarini also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Saldarini also serves on the Syracuse University Board of Visitors and his local Board of Education. Saldarini earned his BA in Political Science and Communications Management from Syracuse University.


Team

www.midatlanticfund.com, 4 July 2015 [cached]

Charles T. Saldarini Venture Advisor

Charles T. Saldarini is a recognized expert in bio-pharmaceutical services and an acknowledged leader and innovator in the field of outsourcing. Saldarini joined Sentrx in April 2009 as CEO, attracted by the company's strong record of performance, its highly experienced investor base, and a compelling core value proposition.
Between 2006 and 2009, Saldarini founded and led The Charles T. Saldarini Group, an independent consulting organization evaluating both emerging and commercial-stage companies in life sciences on behalf of investors seeking opportunities in commercial product development and service company expansion.
Prior to 2006, Saldarini spent eighteen years with PDI, Inc. (NASDAQ: PDII), where he was a major force in driving development of the outsourced contract sales industry. He led PDI from its earliest stage, built its reputation as a premier provider, and drove its annual revenue growth from $1 M to $365 M. Throughout his tenure, he oversaw creation of all infrastructure, systems, and talent growth supporting an employee population of 3,000 and a world-class bio-pharmaceutical client base. Saldarini's leadership enabled a successful public capitalization in 1998, followed by multiple acquisitions and strategic partnerships. At his departure as Vice Chairman and CEO in 2005, PDI was debt free, held over $100 M in cash and was well positioned as a complete commercial services provider.
Saldarini began his career as a sales representative for Merrill-Dow Pharmaceuticals. He earned a bachelor of arts with honors in political science and telecommunications from Syracuse University. Currently, he serves on the boards of Cadient Group , Octagon Clinical Research Solutions, and Informed Medical Communications. Additionally, Saldarini is active in the field of education, serving on the Board of Visitors at Syracuse University, the Board of Advisors at Anisfield School of Business at Ramapo College, and his local school board.


SEC EDGAR Submission 0000930413-05-003565

www.sec.gov, 12 May 2005 [cached]

CHARLES T. SALDARINI, age 41.Mr. Saldarini has been a director since 1997 and is PDI's vice chairman and chief executive officer.Since joining PDI in 1987, Mr. Saldarini has held positions of increasing responsibility, becoming president of PDI in January 1995, chief executive officer in November 1997 and vice chairman in June 2000.In his 18 years at PDI, his contributions have spanned the full range of the Company's development.Prior to joining PDI, Mr. Saldarini worked at Merrill Dow Pharmaceuticals.He received a B.A. in political science from Syracuse University in 1985.


PDI Reports Fourth Quarter and Year End 2003 Financial Results

biz.yahoo.com, 3 Mar 2004 [cached]

Charles T. Saldarini, Vice Chairman and CEO of PDI, stated, "The year 2003 was a pivotal one for PDI.

Similar Profiles

Other People with this Name (52)

Other people with the name Saldarini

Ronald Saldarini

Erin Saldarini
Haddad Subaru

Candace Saldarini

Candace Saldarini
Otsuka America Pharmaceutical Inc

Nancy Saldarini
Syncsort Incorporated

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory